Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERSIST CRSwNP-2: Felcorekibart in Chronic Rhinosinusitis With Nasal Polyps
NCT07782957Phase 3Recruiting
- Sponsor
- GSK
- Start
- Sep 2026
- Primary completion
- Mar 2029
- Countries
- 2
01
Overview
A Phase 3 trial of felcorekibart in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by GSK. Started Sep 2026; status: recruiting.
02
Drugs
felcorekibart
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07782957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07782957.